New Results
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancer
Shunchang Jiao, Yuansheng Zang, Chun Dai, Xiaoman Xu, Xin Cai, Guan Wang, Jinwang Wei, Bing Wu, Wending Sun, Qiang Xu
doi: https://doi.org/10.1101/366062
Shunchang Jiao
Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China;
Yuansheng Zang
Department of Oncology, Shanghai Changzheng Hospital, Shanghai, China;
Chun Dai
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Xiaoman Xu
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Xin Cai
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Guan Wang
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Jinwang Wei
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Bing Wu
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Wending Sun
GenomiCare Biotechnology Co. Ltd., Shanghai, China
Qiang Xu
GenomiCare Biotechnology Co. Ltd., Shanghai, China

Article usage
Posted July 12, 2018.
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancer
Shunchang Jiao, Yuansheng Zang, Chun Dai, Xiaoman Xu, Xin Cai, Guan Wang, Jinwang Wei, Bing Wu, Wending Sun, Qiang Xu
bioRxiv 366062; doi: https://doi.org/10.1101/366062
Subject Area
Subject Areas
- Biochemistry (1493)
- Bioengineering (946)
- Bioinformatics (6831)
- Biophysics (2429)
- Cancer Biology (1792)
- Cell Biology (2530)
- Clinical Trials (106)
- Developmental Biology (1700)
- Ecology (2576)
- Epidemiology (1496)
- Evolutionary Biology (5029)
- Genetics (3623)
- Genomics (4638)
- Immunology (1175)
- Microbiology (4252)
- Molecular Biology (1629)
- Neuroscience (10801)
- Paleontology (83)
- Pathology (240)
- Physiology (555)
- Plant Biology (1459)
- Synthetic Biology (542)
- Systems Biology (1878)
- Zoology (260)